CIK: 0000882095 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 13, 2025
Total Value ($000): $1,181,332 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACLX | ARCELLX INC | 6,720,803 | $440,885 | 37.3% | $86.39 | -21.6% | COMMON STOCK | 03940C100 |
| GLPG | GALAPAGOS NV | 16,707,477 | $419,394 | 35.5% | $27.64 | — | SPON ADR | 36315X101 |
| RCUS | ARCUS BIOSCIENCES INC | 31,424,760 | $246,684 | 20.9% | $16.13 | -28.1% | COM | 03969F109 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 2,209,471 | $21,123 | 1.8% | $16.10 | -18.8% | COM NEW | 045396207 |
| — | MERUS N V | 452,527 | $19,047 | 1.6% | $42.05 | — | COM | N5749R100 |
| KYTX | KYVERNA THERAPEUTICS INC | 4,126,119 | $7,963 | 0.7% | $4.79 | -38.3% | COM | 501976104 |
| TNGX | TANGO THERAPEUTICS INC | 4,854,443 | $6,651 | 0.6% | $4.64 | -47.1% | COM | 87583X109 |
| XLO | XILIO THERAPEUTICS INC | 9,105,451 | $6,596 | 0.6% | $0.98 | -8.6% | COM | 98422T100 |
| KLRS | KALARIS THERAPEUTICS INC | 723,273 | $5,808 | 0.5% | $9.79 | 0.0% | COM | 482929106 |
| HOOK | HOOKIPA PHARMA INC | 1,875,945 | $2,026 | 0.2% | $3.09 | -46.8% | COM NEW | 43906K209 |
| ALLO | ALLOGENE THERAPEUTICS INC | 1,156,689 | $1,689 | 0.1% | $2.47 | -23.6% | COM | 019770106 |
| CYPH | LEAP THERAPEUTICS INC | 5,319,148 | $1,623 | 0.1% | $2.97 | -62.9% | COM NEW | 52187K200 |
| — | IKENA ONCOLOGY INC | 1,159,145 | $1,484 | 0.1% | $1.64 | — | COM | 45175G108 |
| BRNS | BARINTHUS BIOTHERAPEUTICS PL | 369,855 | $360 | 0.0% | $1.21 | — | ADS | 91864C107 |